-
Mashup Score: 15
A study led by researchers at Stanford Medicine finds the benefit of frequent booster vaccination for COVID-19 is highest for those over 65 years and the immunocompromised.
Source: med.stanford.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis - PubMed - 8 month(s) ago
The term heparin resistance (HR) is used by clinicians without specific criteria. We performed a literature search and surveyed our SSC membership to better define the term when applied to medical and ICU patients. The most common heparin dosing strategy reported in the literature 53%) and by survey …
Source: pubmed.ncbi.nlm.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Every Picture Tells A Story – COVID Comes For Republicans - 9 month(s) ago
A study confined to COVID deaths in Florida and Ohio suggests that the Grim Reaper’s “excess” deaths, when stratified by political party, came for Republicans more often than Democrats.
Source: www.acsh.orgCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0Opinion: Post Pandemic Strategies Are Inadequate To Assure Public Safety - 10 month(s) ago
In his analysis, Kevin Kavanagh, MD, explores the measures taken by the infectious disease sector in response to the pandemic, pointing out both effective and ineffective approaches. He also discusses how the pandemic has affected the treatment of other infectious diseases.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19: A systematic review and meta-analysis - 10 month(s) ago
The effect of extended thromboprophylaxis in improving the prognosis of adult patients with coronavirus disease 2019 (COVID-19) after discharge remain…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Weekly Rounds: Antibiotics Duration, Surgical Attire Policy, and Human Metapneumovirus, and More - 11 month(s) ago
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending June 4, 2023.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 3Weekly Rounds: Antibiotics Duration, Surgical Attire Policy, and Human Metapneumovirus, and More - 11 month(s) ago
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending June 4, 2023.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial - PubMed - 12 month(s) ago
gov; Unique identifier: NCT04508023.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1What the Covid-19 pandemic can teach us about drug patents - 1 year(s) ago
“Thirty years after the HIV epidemic, why is there still a time lag of years to get medical products to different regions in the world?” #STATBreakthrough
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
Model estimates who benefits most from frequent #COVID_19 boosters The benefit of frequent booster vaccination for COVID-19 is highest for those over 65 years & the immunocompromised @nathanlo3579 @StanfordMed https://t.co/0hS8xeDPFc